-
The ASAM Weekly for January 14th, 2025
Review of Evidence on Alcohol and HealthFull story
Recent and Past Issues
-
The ASAM Weekly for August 13th, 2024
Physicians not widely adopting evidence-based practices to help reduce addiction morbidity and mortalityFull story -
Guest Editorial: Physicians not widely adopting evidence-based practices to help reduce addiction morbidity and mortality
By now, addiction specialists understand the depth and impact of the drug overdose death crisis in the United States. We’ve read that, “Drug overdoses are one of the leading causes of injury death in adults and have risen over the past several decades… In 2022, 107,941 drug overdose deaths occurred.” Studies published in the past year alone highlight the toll overdose is taking on communities and families, with health disparities and inequities in care often exacerbating negative health outcomes for those most in need.Full story -
The ASAM Weekly for August 6th, 2024
Rapid Initiation of Injectable Extended-Release Naltrexone for Opioid Use Disorder: A Time for Paradigm Shift in Treatment ProtocolsFull story -
Guest Editorial: Rapid Initiation of Injectable Extended-Release Naltrexone for Opioid Use Disorder: A Time for Paradigm Shift in Treatment Protocols
The opioid crisis remains a critical public health issue in the United States, contributing to over 80,000 opioid overdose deaths in 2023 alone.Full story -
The ASAM Weekly for July 30th, 2024
Guest Editorial: Does Rescheduling Cannabis Make Sense?Full story -
Guest Editorial: Does Rescheduling Cannabis Make Sense?
On May 16, the Department of Justice (DOJ) proposed moving marijuana from Schedule I to Schedule III of the Controlled Substances Act. Between now and November’s election, there will be considerable discussion regarding rescheduling.Full story -
The ASAM Weekly for July 23rd, 2024
Guest Editorial: To Address the Fentanyl Crisis, Greater Access to Methadone Is NeededFull story -
Guest Editorial: To Address the Fentanyl Crisis, Greater Access to Methadone Is Needed
Over the past several years, the increasing prevalence of fentanyl in the drug supply has created an unprecedented overdose death rate and other devastating consequences.Full story -
The ASAM Weekly for July 16th, 2024
Benzodiazepine use in relation to long-term dementia riskFull story -
The ASAM Weekly for July 9th, 2024
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trialFull story
This Week in Addiction Medicine Podcast
A weekly audio summary and podcast of the ASAM Weekly
The ASAM Weekly
Editors & Staff
Editor-in-Chief: Nicholas Athanasiou, MD, MBA, DFASAM
Emeritus Editor: William Haning, MD, DFAPA, DFASAM
Publications Chair: Nicholas Athanasiou, MD, MBA, DFASAM
Co-Editors: Brandon
Aden, MD, Jack Woodside, MD, John A. Fromson, MD
Please direct customer service inquiries and comments to: ASAMWeekly@ASAM.org
The ASAM Weekly
Advertiser Services & Sales
Ad space is limited and available on a first-paid, first-published basis. To assure your ad will run in the specific issue you select, Insertion Orders must be signed by an authorized person in your organization and accepted by your customer service representative before taking the advertising units out of the active sales inventory. Payment must be received prior to the run date for an ad. Insertion Orders provide several options for payment in full including all major credit cards or check. Pre-approved billing must be arranged directly by an ASAM representative.
To learn more about advertising opportunities
Contact: Claire Rasmussen <crasmussen@asam.org>